Clinical Nurse Specialist Advanced Pharmacology 1 — Questions and Answers
Question 1: A 70-year-old patient on warfarin for atrial fibrillation is admitted for pneumonia. The patient develops QTc prolongation (QTc 520 ms) on the cardiac monitor. Which antibiotic should the CNS recognize as most likely contributing to QT prolongation?
- Amoxicillin-clavulanate
- Azithromycin (Correct answer)
- Cephalexin
- Trimethoprim-sulfamethoxazole
Correct answer: Azithromycin
Azithromycin (and fluoroquinolones) are well-documented QT-prolonging antibiotics — macrolides inhibit cardiac hERG potassium channels, prolonging ventricular repolarization.
QT prolongation is a significant adverse drug effect that increases risk of Torsades de Pointes (TdP), a potentially fatal ventricular arrhythmia. High-risk antibiotics: macrolides (azithromycin most commonly used — FDA 2013 safety communication), fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin). Mechanism: block cardiac hERG (IKr) potassium channels leading to delayed ventricular repolarization and QT prolongation. Risk factors for drug-induced QT prolongation: female sex, electrolyte abnormalities (hypokalemia, hypomagnesemia), bradycardia, congenital long QT syndrome, baseline QTc >450ms, polypharmacy with multiple QT-prolonging drugs. QTc >500ms or increase of >60ms from baseline = high risk. CNS action: flag the azithromycin, check electrolytes (K+, Mg2+), review all QT-prolonging medications, consult cardiology, consider alternative antibiotic (beta-lactam for community-acquired pneumonia if macrolide not essential).
Question 2: A patient with severe sepsis requires vasopressor support. Norepinephrine has been initiated. The intensivist is considering adding vasopressin. What is the primary pharmacological rationale for vasopressin use in septic shock?
- Vasopressin is a more potent alpha-1 agonist than norepinephrine at equivalent doses
- Vasopressin acts on V1 receptors independently of adrenergic receptors, compensating for relative vasopressin deficiency in septic shock (Correct answer)
- Vasopressin has positive inotropic effects that improve cardiac output in septic shock
- Vasopressin is preferred in septic shock because it does not increase myocardial oxygen demand
Correct answer: Vasopressin acts on V1 receptors independently of adrenergic receptors, compensating for relative vasopressin deficiency in septic shock
Vasopressin acts on V1 (vascular) receptors to cause vasoconstriction independently of adrenergic signaling, compensating for the relative vasopressin deficiency seen in prolonged septic shock.
Arginine vasopressin (AVP) pharmacology in septic shock: (1) Relative vasopressin deficiency: patients in prolonged septic shock have depleted AVP stores and inappropriately low levels for the degree of hypotension, (2) Mechanism: vasopressin acts on V1 receptors (vascular smooth muscle) via IP3/DAG causing vasoconstriction through a non-adrenergic pathway; V2 receptors (renal collecting duct) promote water retention; V1b receptors (pituitary) stimulate ACTH release, (3) Clinical rationale (VASST trial, 2008): low-dose vasopressin (0.03-0.04 units/min) added to norepinephrine — spares catecholamine doses, provides complementary vasoconstriction mechanism, (4) Not an inotrope — vasopressin increases SVR without direct cardiac effects. Surviving Sepsis Campaign guidelines: vasopressin (0.03 units/min) is recommended as second vasopressor to norepinephrine to achieve target MAP or to decrease norepinephrine requirements.
Question 3: A 65-year-old patient with CKD stage 4 (GFR 22 mL/min) requires pain management after total knee replacement. Which opioid selection and dosing consideration is most appropriate?
- Morphine is preferred because it has no active metabolites in renal failure
- Hydromorphone at reduced doses with extended dosing intervals is safer than morphine in significant renal impairment (Correct answer)
- Codeine is appropriate for moderate pain because it requires renal dose adjustment only above 75 years
- Meperidine is preferred for post-operative pain because it avoids the constipation of other opioids
Correct answer: Hydromorphone at reduced doses with extended dosing intervals is safer than morphine in significant renal impairment
Hydromorphone is preferred over morphine in renal impairment; morphine's active metabolite (M6G) accumulates in renal failure causing CNS/respiratory depression.
Opioid selection in renal impairment requires understanding active metabolite accumulation: (1) Morphine: two major metabolites — morphine-3-glucuronide (M3G, neuroexcitatory, no analgesia) and morphine-6-glucuronide (M6G, potent analgesic and respiratory depressant). Both accumulate in renal failure causing prolonged analgesia, sedation, respiratory depression. Avoid in GFR <30 or use with extreme caution; (2) Hydromorphone: primary metabolite hydromorphone-3-glucuronide (H3G) is neuroexcitatory but less potent than M6G; safer than morphine in renal impairment at reduced doses/intervals; (3) Fentanyl: preferred for opioid-tolerant patients with CKD — inactive metabolites, no significant accumulation; (4) Codeine: a prodrug requiring hepatic conversion to morphine — in poor metabolizers it is ineffective; in renal failure, morphine metabolites accumulate; avoid; (5) Meperidine: normeperidine (active metabolite) accumulates in renal failure causing seizures — absolutely contraindicated in renal impairment.
Question 4: A patient on chronic prednisone 20 mg daily for rheumatoid arthritis requires emergency appendectomy. What is the critical perioperative pharmacological concern?
- Risk of postoperative bleeding due to prednisone's antiplatelet effects
- Hypothalamic-pituitary-adrenal (HPA) axis suppression requiring stress-dose steroids (Correct answer)
- Increased risk of prednisone toxicity due to surgical anesthesia interactions
- Need to discontinue prednisone 48 hours preoperatively to prevent wound dehiscence
Correct answer: Hypothalamic-pituitary-adrenal (HPA) axis suppression requiring stress-dose steroids
Chronic glucocorticoid use suppresses the HPA axis; surgical stress requires cortisol surge that suppressed adrenal glands cannot produce — stress-dose steroids prevent adrenal crisis.
HPA axis suppression pharmacology: (1) Exogenous glucocorticoids suppress CRH (hypothalamus) leading to ACTH (pituitary) suppression and reduced cortisol (adrenal) production through negative feedback; doses >=5 mg prednisone daily for >3 weeks cause significant suppression; (2) Normal cortisol response to major surgery: 75-150 mg/day (vs. baseline 10-30 mg/day); (3) Risk: HPA-suppressed patients cannot mount this cortisol surge leading to hemodynamic instability, hypotension, cardiovascular collapse (adrenal crisis); (4) Stress-dose steroid protocol: for major surgery — hydrocortisone 100 mg IV at induction, then 50 mg IV every 8 hours for 24-48h, then taper to usual dose over 1-2 days. The threshold: prednisone >=20 mg/day x >3 weeks = high risk, likely suppressed HPA. CNS must communicate this risk to the anesthesia and surgical teams and ensure stress-dose steroids are ordered. Failure to do so is a preventable patient safety event.
Question 5: A CNS reviewing a patient's medication list notes the patient takes simvastatin 80 mg and has been newly prescribed clarithromycin for H. pylori. What is the critical drug interaction concern?
- Clarithromycin reduces simvastatin efficacy by inducing CYP3A4 metabolism
- Clarithromycin inhibits CYP3A4, dramatically increasing simvastatin levels and risk of rhabdomyolysis (Correct answer)
- The combination increases clarithromycin levels, requiring dose reduction of the antibiotic
- There is no clinically significant interaction between these two medications
Correct answer: Clarithromycin inhibits CYP3A4, dramatically increasing simvastatin levels and risk of rhabdomyolysis
Clarithromycin is a potent CYP3A4 inhibitor; simvastatin is a CYP3A4 substrate — co-administration dramatically increases simvastatin AUC (up to 10-fold), causing severe rhabdomyolysis risk.
CYP3A4 drug interactions are among the most clinically significant. Clarithromycin: potent CYP3A4 inhibitor (also inhibits P-glycoprotein). Simvastatin: highly CYP3A4-dependent metabolism; 80 mg is already the maximum recommended dose (FDA 2011 safety communication limiting 80 mg use). Co-administration: clarithromycin inhibits CYP3A4 leading to reduced simvastatin first-pass metabolism, dramatically elevated simvastatin AUC (up to 10-fold), and severe myopathy/rhabdomyolysis risk. Rhabdomyolysis: skeletal muscle breakdown leading to myoglobinuria and acute kidney injury. The package insert for simvastatin contraindicates co-administration with clarithromycin. CNS action: flag this contraindicated combination immediately, recommend switching to azithromycin (less potent CYP3A4 interaction) or holding simvastatin during the antibiotic course, and educating the prescriber. Lovastatin has the same issue; pravastatin, rosuvastatin, and fluvastatin are not significantly CYP3A4-dependent and are safer alternatives.
Question 6: A patient in the ICU requires sedation management. The CNS is implementing the ABCDEF bundle. Which sedation agent is most appropriate per current evidence for mechanically ventilated patients, and what is the preferred sedation target?
- Propofol targeting deep sedation (RASS -4 to -5) to ensure patient comfort
- Dexmedetomidine or propofol targeting light sedation (RASS -1 to 0) per PADIS guidelines (Correct answer)
- Benzodiazepines (lorazepam) targeting moderate sedation (RASS -2 to -3) as standard of care
- Ketamine for analgesia-first sedation targeting complete dissociation from environment
Correct answer: Dexmedetomidine or propofol targeting light sedation (RASS -1 to 0) per PADIS guidelines
PADIS guidelines (2018) recommend light sedation targets (RASS -1 to 0) with non-benzodiazepine agents (dexmedetomidine, propofol); benzodiazepines increase delirium risk.
2018 SCCM PADIS Clinical Practice Guidelines (updated from 2013 PAD guidelines): (1) Sedation target: light sedation (RASS -1 to 0 or equivalent) is associated with reduced ICU LOS, shorter mechanical ventilation, reduced delirium, and improved outcomes vs. deep sedation; (2) Agent preference: propofol or dexmedetomidine over benzodiazepines (lorazepam, midazolam) — benzodiazepines significantly increase delirium risk (MENDS, SEDCOM, MIDEX/PRODEX trials); (3) Analgesia-first approach: treat pain before adding sedation (AnalgoSedation or analgesia-first approach); (4) Dexmedetomidine: alpha-2 agonist, sedation with arousability (rousable to voice), reduces delirium, allows neurological assessment, preserves respiratory drive (can reduce MV duration); (5) Daily SAT/SBT: spontaneous awakening trials paired with spontaneous breathing trials. The CNS implements ABCDEF bundle systematically, targeting RASS -1 to 0 as the default goal.
Clinical Nurse Specialist Advanced Pharmacology 1
A 70-year-old patient on warfarin for atrial fibrillation is admitted for pneumonia.
The patient develops QTc prolongation (QTc 520 ms) on the cardiac monitor.
Which antibiotic should the CNS recognize as most likely contributing to QT prolongation?